Latest from The Phage
Fresh stories, protocols, and interviews from the phage world.
PHAXIAM Therapeutics and Vetophage Join Forces to Combat Antimicrobial Resistance
Lyon, France, and Cambridge, MA, USA, October 2023, PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) and Vetophage, a Lyon-based company specializing in phage…
The Deepest Known Isolated Phage: A Virus from the Mariana Trench
In a groundbreaking discovery that has captivated the scientific community, a novel virus has been found in the abyssal depths of the…
Phage Therapy Breaks New Ground in Combating Drug-Resistant Mycobacterial Infections
In the ongoing battle against drug-resistant Mycobacterial infections, a ray of hope has emerged from the world of bacteriophages. The study, titled…
Phage Facilitates Nitrogen Metabolism in Newly Discovered Deep-sea Bacteria
Scientists have made important progress in understanding deep-sea Planctomycetes bacteria. These bacteria are found in various ecosystems and play a vital role…
Phage-Powered Evolution Unleashes Compact and Mighty Prime Editors
In the mesmerizing world of genetic engineering, prime editing has emerged as a shining star, promising to rewrite the very fabric of…
Pharokka: Empowering Phage Genomic Annotation
In 21st-century research, where sequences burgeon, the demand for efficient and scalable genomic annotation tools has never been more pronounced. The recent…